168 related articles for article (PubMed ID: 21730350)
1. Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD.
Haq I; Lowrey GE; Kalsheker N; Johnson SR
Thorax; 2011 Nov; 66(11):970-6. PubMed ID: 21730350
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphism in promoter regions of matrix metalloproteinases (MMP1, MMP9, and MMP12) in chronic obstructive pulmonary disease patients].
Korytina GF; Akhmadishina LZ; Ianbaeva DG; Viktorova TV
Genetika; 2008 Feb; 44(2):242-9. PubMed ID: 18619044
[TBL] [Abstract][Full Text] [Related]
3. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease.
Molet S; Belleguic C; Lena H; Germain N; Bertrand CP; Shapiro SD; Planquois JM; Delaval P; Lagente V
Inflamm Res; 2005 Jan; 54(1):31-6. PubMed ID: 15723202
[TBL] [Abstract][Full Text] [Related]
4. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.
Minematsu N; Nakamura H; Tateno H; Nakajima T; Yamaguchi K
Biochem Biophys Res Commun; 2001 Nov; 289(1):116-9. PubMed ID: 11708786
[TBL] [Abstract][Full Text] [Related]
6. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
7. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
8. Elevated MMP-12 protein levels in induced sputum from patients with COPD.
Demedts IK; Morel-Montero A; Lebecque S; Pacheco Y; Cataldo D; Joos GF; Pauwels RA; Brusselle GG
Thorax; 2006 Mar; 61(3):196-201. PubMed ID: 16308335
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats.
Xu L; Cai BQ; Zhu YJ
Chin Med J (Engl); 2004 Nov; 117(11):1611-9. PubMed ID: 15569474
[TBL] [Abstract][Full Text] [Related]
10. Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients.
Hizawa N; Makita H; Nasuhara Y; Hasegawa M; Nagai K; Ito Y; Betsuyaku T; Konno S; Nishimura M;
Eur Respir J; 2008 Aug; 32(2):372-8. PubMed ID: 18385174
[TBL] [Abstract][Full Text] [Related]
11. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema.
Lambrechts D; Buysschaert I; Zanen P; Coolen J; Lays N; Cuppens H; Groen HJ; Dewever W; van Klaveren RJ; Verschakelen J; Wijmenga C; Postma DS; Decramer M; Janssens W
Am J Respir Crit Care Med; 2010 Mar; 181(5):486-93. PubMed ID: 20007924
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Ito I; Nagai S; Handa T; Muro S; Hirai T; Tsukino M; Mishima M
Am J Respir Crit Care Med; 2005 Dec; 172(11):1378-82. PubMed ID: 16126934
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease].
Chen Y; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease.
Cheng SL; Yu CJ; Yang PC
Biochem Genet; 2009 Aug; 47(7-8):591-601. PubMed ID: 19507017
[TBL] [Abstract][Full Text] [Related]
15. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.
Russell RE; Culpitt SV; DeMatos C; Donnelly L; Smith M; Wiggins J; Barnes PJ
Am J Respir Cell Mol Biol; 2002 May; 26(5):602-9. PubMed ID: 11970913
[TBL] [Abstract][Full Text] [Related]
16. [Airway inflammation and macrophage inflammatory protein-1alpha, gelatinase B level in patients with COPD].
Cai S; Chen P; Zhu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jul; 24(7):429-32. PubMed ID: 11803002
[TBL] [Abstract][Full Text] [Related]
17. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
Mercer PF; Shute JK; Bhowmik A; Donaldson GC; Wedzicha JA; Warner JA
Respir Res; 2005 Dec; 6(1):151. PubMed ID: 16372907
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China.
Zhou M; Huang SG; Wan HY; Li B; Deng WW; Li M
Chin Med J (Engl); 2004 Oct; 117(10):1481-4. PubMed ID: 15498369
[TBL] [Abstract][Full Text] [Related]
19. Matrix Metalloproteinase-28 Is a Key Contributor to Emphysema Pathogenesis.
Manicone AM; Gharib SA; Gong KQ; Eddy WE; Long ME; Frevert CW; Altemeier WA; Parks WC; Houghton AM
Am J Pathol; 2017 Jun; 187(6):1288-1300. PubMed ID: 28399390
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema.
Wallace AM; Sandford AJ; English JC; Burkett KM; Li H; Finley RJ; Müller NL; Coxson HO; Paré PD; Abboud RT
COPD; 2008 Feb; 5(1):13-23. PubMed ID: 18259971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
